Cite
HARVARD Citation
Reck, M. et al. (2020). Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy. Lung cancer. pp. 159-165. [Online].